Excellent Early and Major Molecular Responses Observed with Asciminib Treatment for CP-CML: Results from the ALLG CML13 Ascend-CML Study

David T Yeung, On Behalf of the ALLG, John Reynolds et al.|Blood|2023

Cited by 5